Emerging Risk of Ethanol-related Outbreak via Clandestine Alcohol Consumption During Pregnancy: An Alarming Note on Prevention of Fetal Alcohol Spectrum Disorders in Iran

authors:

avatar Fahimeh Mohseni ORCID 1 , avatar Mehdi Khaksari 2 , avatar Maryam Khoramrooz ORCID 3 , avatar Raheleh Rafaiee 4 , avatar Seyed Mohammad Mirrezaie 1 , *

Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran
Addiction Research Center, Shahroud University of Medical Sciences, Shahroud, Iran
Department of Health Management and Economics, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran
Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran

how to cite: Mohseni F, Khaksari M, Khoramrooz M, Rafaiee R, Mirrezaie S M. Emerging Risk of Ethanol-related Outbreak via Clandestine Alcohol Consumption During Pregnancy: An Alarming Note on Prevention of Fetal Alcohol Spectrum Disorders in Iran. Int J High Risk Behav Addict. 2023;12(1):e131881. https://doi.org/10.5812/ijhrba-131881.

Dear Editor,

Alcohol consumption during pregnancy is an increased risk behavior that raises significant clinical concerns. Ethanol is classified as a hazardous teratogenic substance (1). Possible alcohol-related defects include stillbirth, spontaneous miscarriage, premature birth, low birth weight, growth restriction, learning deficits, and some social problems later in life. In addition, numerous studies have shown that alcohol might cause more fetal malformations than cocaine, heroin, and marijuana (2).

No amount of ethanol is known to be safely consumed during pregnancy. Studies have shown that even low-level prenatal alcohol exposure can lead to invisible disabilities related to brain dysfunction, which in turn can lead to learning, memory, and behavioral problems in adulthood (1). The severity of alcohol-related effects on the fetus depends on the mother’s drinking patterns (i.e., frequency and quantity); for example, continuous moderate to high maternal alcohol consumption (binge drinking) leads to a dramatic manifestation of ethanol-related physical, mental, and behavioral retardation known as fetal alcohol spectrum disorders (FASDs) (3). Historically, much attention has been given to studying alcohol abuse disorders in men because they are more likely to drink, binge drink, and have alcohol use disorders and ethanol-related deaths than women. With psycho-socio-cultural influences, more women drink and heavily drink; accordingly, female-male differences in ethanol consumption are decreasing (4).

Today, nearly one-third of individuals with alcohol problems worldwide are female (5). In addition, ethanol consumption is rising at an awareness rate among women worldwide, especially among women of reproductive age (range: 15 - 49 years) and pregnant women (1). Globally, the estimated prevalence of ethanol use during pregnancy was around 9.8% (6).

In 40% of the studied countries, more than a quarter of pregnant women consume alcoholic drinks in excess (binge drinking) (1). In Iran, the epidemiology regarding alcohol consumption is not accurate. Iranian alcohol abusers, especially women, prefer to hide their problems. This could be due to the prevailing conservative sociocultural and religious context and the criminalization of alcohol consumption by the Islamic government (7). Some events, such as the outbreak of methanol poisoning (8) and the discovery of large quantities of illegal alcoholic beverages by the police (9), confirm the existence of clandestine consumption.

There are few studies on alcohol consumption during pregnancy in Iran. A study by Tavafian and Ramazanzadeh showed that the rate of alcohol use was 0.2% among the studied Iranian pregnant participants (10). Moreover, based on a published paper in the Lancet Global Health in 2017, Iran is one of the countries where alcohol use during pregnancy in the general population was estimated to be around < 0.5% (11).

Furthermore, a recent study by Ranjbar et al. in Iran showed that the prevalence of alcohol use during pregnancy was higher in mothers of children with physical abnormalities than in mothers with healthy children (12). This study did not investigate whether or not it was FASD-related retardation, and no other study in Iran investigated this subject. However, available data show that alcohol consumption by Iranian women of childbearing age is increasing (13). Therefore, if preventive policies are not considered, the healthcare system might face ethanol-related neonatal defects, such as FASDs, shortly that could have been previously prevented.

Prenatal and other healthcare providers must communicate an evidence-based transparent awareness to women about the risks of ethanol drinking during pregnancy, such as FASDs. Physicians should inform all women to avoid any amount of ethanol throughout pregnancy and when to decide to become pregnant, emphasizing the benefits to maternal and neonatal well-being and health. Education can come from various sources, including government guidelines, health organizations, media, and premarital education programs.

Additionally, detecting cases of ethanol use is paramount to improving maternal and neonatal health and preventing FASD cases. Screening is an effective population-based policy to reduce harmful ethanol consumption worldwide (14) and can be implemented in Iran. During each pregnancy, prenatal care providers can use ethanol screening programs and methods in their clinical care to detect prenatal alcohol exposure and reduce associated harms. To date, there have been no studies or even case reports of fetal alcohol syndrome in Iran. This letter is the first one written about fetal alcohol syndrome in Iran. The purpose of this letter was to inform and alert and make the proposal to be accepted. With this letter, the authors would like to be heard by health policymakers. The authors also would like to express their concern as health professionals about the potential risk of ethanol-related outbreaks due to clandestine alcohol use during pregnancy.

References

  • 1.

    Popova S, Dozet D, Shield K, Rehm J, Burd L. Alcohol's Impact on the Fetus. Nutrients. 2021;13(10). [PubMed ID: 34684453]. [PubMed Central ID: PMC8541151]. https://doi.org/10.3390/nu13103452.

  • 2.

    Mohammadzadeh A, Farhat A. Fetal alcohol syndrome. Asia Pac J Med Toxicol. 2014;3(Supplement 1):10. https://doi.org/10.22038/apjmt.2014.2883.

  • 3.

    Mattson SN, Crocker N, Nguyen TT. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychol Rev. 2011;21(2):81-101. [PubMed ID: 21503685]. [PubMed Central ID: PMC3410672]. https://doi.org/10.1007/s11065-011-9167-9.

  • 4.

    Baker FC, Carskadon MA, Hasler BP. Sleep and Women's Health: Sex- and Age-Specific Contributors to Alcohol Use Disorders. J Womens Health (Larchmt). 2020;29(3):443-5. [PubMed ID: 32119636]. [PubMed Central ID: PMC7097695]. https://doi.org/10.1089/jwh.2020.8328.

  • 5.

    Oei JL. Alcohol use in pregnancy and its impact on the mother and child. Addiction. 2020;115(11):2148-63. [PubMed ID: 32149441]. https://doi.org/10.1111/add.15036.

  • 6.

    Popova S, Lange S, Probst C, Gmel G, Rehm J. Global prevalence of alcohol use and binge drinking during pregnancy, and fetal alcohol spectrum disorder. Biochem Cell Biol. 2018;96(2):237-40. [PubMed ID: 28834683]. https://doi.org/10.1139/bcb-2017-0077.

  • 7.

    Mohseni F, Rafaiee R. Results of Activity of Anonymous Alcoholic Association in Iran. Addict Health. 2018;10(1):11-6. [PubMed ID: 30627380]. [PubMed Central ID: PMC6312557]. https://doi.org/10.22122/ahj.v10i1.554.

  • 8.

    Hassanian-Moghaddam H, Zamani N, Roberts DM, Brent J, McMartin K, Aaron C, et al. Consensus statements on the approach to patients in a methanol poisoning outbreak. Clin Toxicol (Phila). 2019;57(12):1129-36. [PubMed ID: 31328583]. https://doi.org/10.1080/15563650.2019.1636992.

  • 9.

    Solgi R, Taheri-Kamalan L, Larki-Harchegani A, Nili-Ahmadabadi A. Increased production of illegal alcoholic beverages during the COVID-19 pandemic in Hamadan, Iran. Forensic Toxicol. 2021;39(2):518-21. [PubMed ID: 34025810]. [PubMed Central ID: PMC8130790]. https://doi.org/10.1007/s11419-021-00583-w.

  • 10.

    Tavafian SAS, Ramazanzadeh F. Cigarette smoking, illicit medicine, substance and alcohol abuse among pregnant women: a cross sectional study from Iran. International Journal of Fertility and Sterility. 2008;2(1):35-8.

  • 11.

    Popova S, Lange S, Probst C, Gmel G, Rehm J. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(3):e290-9. [PubMed ID: 28089487]. https://doi.org/10.1016/S2214-109X(17)30021-9.

  • 12.

    Ranjbar M, Masoudnia E, Haghshenas Mojaver M. A Comparative Study on Psychosocial Factors between Mothers of Infants with and without Physical Abnormalities. J Holist Nurs Midwifery. 2021;31(1):26-34. https://doi.org/10.32598/jhnm.31.1.2027.

  • 13.

    Ansari-Moghaddam A, Rakhshani F, Shahraki-Sanavi F, Mohammadi M, Miri-Bonjar M, Bakhshani NM. Prevalence and patterns of tobacco, alcohol, and drug use among Iranian adolescents: A meta-analysis of 58 studies. Child Youth Serv Rev. 2016;60:68-79. https://doi.org/10.1016/j.childyouth.2015.11.018.

  • 14.

    Dozet D, Burd L, Popova S. Screening for Alcohol Use in Pregnancy: a Review of Current Practices and Perspectives. Int J Ment Health Addict. 2021:1-20. [PubMed ID: 34580577]. [PubMed Central ID: PMC8457028]. https://doi.org/10.1007/s11469-021-00655-3.